[Etiotropic treatment of patients with early uterine carcinoma as a basis for prevention of relapses and complications].
In this paper, consideration is given to the role that etiological and pathogenetic factors have in the development of malignant tumours. Prevention of possible recurrencies and complications in patients with incipient forms of hysterocarcinoma warrant etiotropic treatment which has been shown to be effective and essential for the object to succeed in.
Iaremchuk
A Ia
AIa
Vakulenko
G A
GA
Khadi
D
D
D042462:4-Quinolones; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000994:Antitrichomonal Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy; D002177:Candidiasis / Q000150:complications / Q000188:drug therapy; D005260:Female; D024841:Fluoroquinolones; D006801:Humans; D018942:Macrolides; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D011379:Prognosis; D012307:Risk Factors; D014245:Trichomonas Infections / Q000150:complications / Q000188:drug therapy; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control*
D042462:4-Quinolones; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000935:Antifungal Agents; D000994:Antitrichomonal Agents; D024841:Fluoroquinolones; D018942:Macrolides
Etiotropnoe lechenie bol'nykh s nachal'nymi formami raka sheĭki matki kak osnova preduprezhdeniia retsidivov i oslozhneniĭ.